Lataa...
The promises and challenges of erythropoietin for treatment of Alzheimer’s disease
Alzheimer’s disease (AD) is the most prevalent neurodegenerative disorder in the world, and intracellular neurofibrillary tangles and extracellular amyloid-beta protein deposits represent the major pathological hallmarks of the disease. Currently available treatments provide some symptomatic relief...
Tallennettuna:
| Julkaisussa: | Neuromolecular Med |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6407698/ https://ncbi.nlm.nih.gov/pubmed/30656553 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12017-019-08524-y |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|